Back to results
US 10,767,212 B2Granted
Method of screening compounds
AssigneeCornell University
InventorsRichard Cerione, Jon W Erickson, Clint A Stalnecker
Life of this patent
Estimating the term…
Abstract
The present technology relates to kidney-type glutaminase (GLS) proteins that have a phenylalanine to tryptophan substitution at the position corresponding to residue 322 of human glutaminase C (GAC), and methods of using such proteins to screen for compounds that bind to the activation loop of GLS and/or modulate glutaminase activity of GLS.
Claims9
A method of screening for compounds that bind to the activation loop of kidney-type glutaminase (“GLS”) protein, said method comprising:
- contacting GLS protein, wherein the GLS protein comprises an activation loop and comprises a phenylalanine to tryptophan substitution at the residue corresponding to position 322 of SEQ ID NO:
- 2, with a test compound, wherein the test compound is a compound that potentially binds to the activation loop, to permit binding between the activation loop and the test compound;
- detecting fluorescence of the substituted tryptophan in the presence of the test compound;
- comparing the detected fluorescence to fluorescence of a control;
- and
- identifying, based on said comparing, that the test compound is a compound that binds to the activation loop of GLS, wherein a change in fluorescence relative to the control indicates that the test compound binds to the activation loop.
3 more elements
Dependencies are inferred from the claim text.